1. Home
  2. VTRS vs WYNN Comparison

VTRS vs WYNN Comparison

Compare VTRS & WYNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$10.94

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Logo Wynn Resorts Limited Common stock

WYNN

Wynn Resorts Limited Common stock

HOLD

Current Price

$125.53

Market Cap

13.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTRS
WYNN
Founded
1961
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
13.5B
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
VTRS
WYNN
Price
$10.94
$125.53
Analyst Decision
Hold
Strong Buy
Analyst Count
6
13
Target Price
$11.17
$139.31
AVG Volume (30 Days)
7.9M
1.7M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
4.39%
0.80%
EPS Growth
N/A
N/A
EPS
N/A
4.59
Revenue
$14,124,400,000.00
$7,110,738,000.00
Revenue This Year
N/A
$1.96
Revenue Next Year
$1.16
$3.59
P/E Ratio
N/A
$27.36
Revenue Growth
N/A
N/A
52 Week Low
$6.85
$65.25
52 Week High
$13.13
$134.72

Technical Indicators

Market Signals
Indicator
VTRS
WYNN
Relative Strength Index (RSI) 60.39 50.63
Support Level $10.67 $123.34
Resistance Level $10.93 $133.98
Average True Range (ATR) 0.24 4.26
MACD 0.01 0.37
Stochastic Oscillator 90.23 53.49

Price Performance

Historical Comparison
VTRS
WYNN

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About WYNN Wynn Resorts Limited Common stock

Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform, in a few states. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.

Share on Social Networks: